Skip to content
  • News
  • Contacts
  • Careers
  •  
    • Kedrion Corporate
    • Kedrion Biopharma GmbH
    • Kedrion Biopharma – Austria
    • Kedrion Biopharma – Portugal
    • Kedrion Biopharma – Poland
    • Kedrion Biopharma – Switzerland
    • Kedrion Biopharma – Russia
    • HUMAN Bioplazma Kft
    • Kedrion Biopharma Inc.
    • Kedrion Mexicana S.A.
    • Kedrion de Colombia
    • Kedrion Betaphar
    • KEDPLASMA USA
  •  
  •  
    • LinkedIn
  • English
    • Italiano
  • About Us
    • Corporate Structure
    • Annual Report
    • Corporate Social Responsibility
      • Environment, Health & Safety
      • Supporting our people
      • Support to communities
    • Corporate Governance System (It.Leg.Decree 231/2001)
    • Compliance to Antitrust Law
    • Transparency disclosures
    • Personal data disclosure
  • Expertise
    • Activities
    • Medical & Scientific Information
    • Research & Development
    • Quality & Safety
  • Therapies
    • Therapeutic areas
      • Rare Diseases
      • Mother and Child Health
      • Critical care and transplantation
      • Transfusion Medicine
  • Services
    • Contract manufacturing
    • Technology transfer
    • Biological Safety Centre
    • Italian partnership
      • From Collection to Distribution: The Flow of Life
      • Kedrion Standard Quality Practices
  • Donors
    • Plasma
  • Pharmacovigilance
Find in Kedrion

Credits

Images by:

Christian Sinibaldi, Photographer
www.christiansinibaldi.com

Kedrion

Kedrion S.p.A. with sole Shareholder
Subject to control and coordination of Kedrion Holding SpA

Registered Office: Loc. Ai Conti snc, Castelvecchio Pascoli, 55051-Barga (LU)

CF – PI Registro delle Imprese della TOSCANA NORD-OVEST N° REA LU – 01779530466
Cap. Soc. i.v. euro 60.453.901,00

INFORMATION

  • Credits
  • Site Map
  • Cookies
  • Terms of Use

HIGHLIGHTS

  • Biological Safety Centre
  • Annual Report

Where We Are

© Kedrion 2023 / Kedrion S.p.A

You are now leaving www.kedrion.it. Medical information including licensed uses may be different outside of Italy.

error: Content is protected !!
Kedrion BiopharmaLogo Header Menu
    • English
    • Italiano
    • About Us
      • Corporate Structure
      • Annual Report
      • Corporate Social Responsibility
        • Environment, Health & Safety
        • Supporting our people
        • Support to communities
      • Corporate Governance System (It.Leg.Decree 231/2001)
      • Compliance to Antitrust Law
      • Transparency disclosures
      • Personal data disclosure
    • Expertise
      • Activities
      • Medical & Scientific Information
      • Research & Development
      • Quality & Safety
    • Therapies
      • Therapeutic areas
        • Rare Diseases
        • Mother and Child Health
        • Critical care and transplantation
        • Transfusion Medicine
    • Services
      • Contract manufacturing
      • Technology transfer
      • Biological Safety Centre
      • Italian partnership
        • From Collection to Distribution: The Flow of Life
        • Kedrion Standard Quality Practices
    • Donors
      • Plasma
    • Pharmacovigilance
  • News
  • Contact
  • Careers
  • Kedrion’s Sites
    • Kedrion Corporate
    • Kedrion Biopharma GmbH
    • Kedrion Biopharma – Austria
    • Kedrion Biopharma – Portugal
    • Kedrion Biopharma – Poland
    • Kedrion Biopharma – Russia
    • HUMAN Bioplazma Kft
    • Kedrion Biopharma Inc.
    • Kedrion Mexicana S.A.
    • KEDPLASMA USA
    • Kedrion Betaphar
  • Social
    • LinkedIn